0 Комментарии
0 Поделились
933 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Offers
-
Jobs
-
Courses
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Small Molecule Innovator API CDMO Market Trends in Process Development and Scale-UpThe global Small Molecule Innovator API CDMO market was valued at USD 26.7 billion in 2025 and is projected to grow from USD 28.1 billion in 2026 to USD 43.7 billion by 2033, registering a CAGR of 6.6% from 2026 to 2033. Asia Pacific accounted for the largest 41.9% revenue share in 2025, supported by expanding pharmaceutical manufacturing capabilities, cost-efficient production...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Small Molecule Innovator API CDMO Market Sees Rising Adoption in Clinical-Stage Drug Development, Commercial API Manufacturing, and Lifecycle ManagementMarket Overview The Small Molecule Innovator API CDMO Market is gaining importance as pharmaceutical companies increasingly outsource active pharmaceutical ingredient development and manufacturing to specialized contract development and manufacturing organizations. Innovator drug developers often require advanced capabilities for complex molecules, stringent quality control,...0 Комментарии 0 Поделились 305 Просмотры 0 предпросмотр
-
Synthetic Small Molecule API Market: Growth Trends, Industry Analysis, and Forecast 2034The pharmaceutical industry continues to evolve rapidly as demand grows for effective, affordable, and high-quality medicines. At the core of every pharmaceutical formulation lies the active pharmaceutical ingredient (API), the component responsible for delivering the intended therapeutic effect. Among the various types of APIs, synthetic small molecules remain the backbone of drug development...0 Комментарии 0 Поделились 879 Просмотры 0 предпросмотр